Search results
ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Investing.com· 1 day agoICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 11 hours agoThis decision comes after recent consultations with the U.S. Food and Drug Administration (FDA) and...
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
KFDX Wichita Falls· 3 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
Jacksonville research group seeks participants for new COVID-19 vaccine trial
WJXT Jacksonville· 5 hours agoResearchers at the Jacksonville Center for Clinical Research (JCCR) are recruiting people to...
Sedana Medical completes patient recruitment for its clinical program in the US
WKBN 27 Youngstown· 23 hours agoEarlier this spring, Sedana Medical reported the completion of enrolment to the parallel phase III clinical trial ...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical ...
Insmed stocks soar as Phase III lung disease drug exceeds expectations
Clinical Trials Arena via Yahoo Finance· 19 hours agoThe highly anticipated ASPEN trial (NCT04594369) was a global, randomised, double-blind,...
Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in...
FOX 23 News Albany· 9 hours agoJeffrey M. Statland, M.D., Professor of Neurology, University of Kansas Medical Center, and FORTITUDE™ trial investigator, will present ...
...Bioscience Announces First Patient Dosed in Phase 1/2 Clinical Trial of TSN1611, a Selective and...
FOX 4 Kansas City· 6 days agoTyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 6 days ago(NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing...